24 days to the next MRMD/MRSO MR Safety Training Course-Washington, DC; send me (ekanal@pitt.edu) your questions to discuss at the course!
For clarification: Kanal's MR Safety implant Risk Assessment app can be accessed/purchased by anyone directly via: itunes.apple.com/us/app/kana…
Kanal's MR Safety implant Risk Assessment app now downloaded several hundred times at no charge by recent attendees of my MRMD/MRSO courses
Kanal's MR Safety Implant Risk Assessment app is now free to attendees of my MR safety courses from past 12 months
Effective immediately all Kanal MRMD/MRSO MR Safety Training Courses will start 4 PM Sunday, 3 full days, 2 more CEs, NO change in reg fees
Formalization of recommended organizational structure of those charged with MR safety oversight has finally arrived oshwiki.eu/wiki/Recommended_…
Registration for 2016 ABMRS examinations (April 13 Chicago, July 27 Las Vegas, November 16 DC) to open today at 9 am Eastern Time.
Registration for the 2016 ABMRS certification examinations will open 9 am Eastern Time Monday, January 11, 2016 @ abmrs.org
More than 200 have registered for the October 19-21, 2015 MRMD/MRSO Safety Course. Looking forward to seeing you all in Orlando in 1 month!
1 month to the next MRMD/MRSO Safety Course. Send me your safety questions; they'll be discussed in the course itself. ekanal@pitt.edu
It's official... The ABMRS MRSE exam will be offered 10/21/15 for the 1st time along with the MRMD&MRSO exams-registration is already open!
A6b: Also unclear where else Gd accumulates (brain, bone…). Suggest: Identify known Gd toxicity symptoms and screen repeat exposed pts #AJNR
A6a: Unknown. Ideas: Evaluate for abn dentate fn? Evaluate repeat exposed pts with no underlying disease (e.g., breast ca screens). #AJNR
Thank you! For f/u questions, discussion, references, etc. feel free/encouraged to contact me directly at ekanal@pitt.edu #AJNR
The last few years have taught us there are clear differences among the various GBCA. We should not treat them as interchangeable #AJNR
Some of these questions/issues are VERY complex - not ideal content for twitter communications... #AJNR
A5b:For legal exposure/malpractice, must document a duty to the patient, not having provided that duty, and secondary proximate injury #AJNR
A5: Only if proximate injury from usage of these agents can eventually be clearly shown to exist #AJNR
A4b: The one taking an unknown, if any, risk (the pt.) is not the one receiving the (financial) benefit of using those specific agents #AJNR